Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - Related Studies

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

This study is currently recruiting participants.

Study NCT00643097. Last updated on September 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Central Nervous System Neoplasms
		Glioblastoma
		Nervous System Neoplasms

2	More general conditions related to this trial
		Astrocytoma
		Glioma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Nervous System Diseases
		Neuroectodermal Tumors

3	Interventions listed in this trial
		PEP-3-KLH conjugate vaccine
		placebo
		sargramostim

4	Sponsors listed in this trial
		Duke University
		National Cancer Institute (NCI)